Myocardial tissue engineering is a promising therapy for myocardial infarction recovery. The success of myocardial tissue engineering is likely to rely on the combination of cardiomyocytes, prosurvival regulatory signals, and a flexible biomaterial structure that can deliver them. In this study, poly(glycerol sebacate) (PGS), which exhibits stable elasticity under repeated tensile loading, was engineered to provide physical features that aligned cardiomyocytes in a similar manner to that seen in native cardiac tissue. In addition, a small molecule mimetic of brain derived neurotrophic factor (BDNF) was polymerized into the PGS to achieve a continuous and steady release. Micropatterning of PGS elastomers increased cell alignment, calcium tr...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
There is currently an overwhelming need for functional replacement of diseased or damaged cardiac ti...
Dilated cardiomyopathy is a major cause of progressive heart failure. Utilization of stem cell thera...
Myocardial tissue engineering is a promising therapy for myocardial infarction recovery. The success...
Myocardial tissue engineering is a promising therapy for myocardial infarction recovery. The success...
Poly (glycerol sebacate) (PGS) is a biodegradable crosslinked polyester elastomer. Due to its hemoco...
A significant challenge in cardiac tissue engineering is the development of biomimetic grafts that c...
Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of hea...
Heart tissue engineering is critical in the treatment of myocardial infarction, which may benefit ...
Tissue engineering approaches are currently being investigated for the restoration of myocardial fun...
The heart does not regenerate new functional tissue when myocardium dies following coronary artery o...
AbstractOne of the major challenges in the field of biomaterials engineering is the replication of t...
High-purity cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are prom...
Heart failure is one of the most debilitating diseases today, and is responsible for one third of al...
Cardiovascular disease is the leading cause of death worldwide. Due to the extremely low natural reg...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
There is currently an overwhelming need for functional replacement of diseased or damaged cardiac ti...
Dilated cardiomyopathy is a major cause of progressive heart failure. Utilization of stem cell thera...
Myocardial tissue engineering is a promising therapy for myocardial infarction recovery. The success...
Myocardial tissue engineering is a promising therapy for myocardial infarction recovery. The success...
Poly (glycerol sebacate) (PGS) is a biodegradable crosslinked polyester elastomer. Due to its hemoco...
A significant challenge in cardiac tissue engineering is the development of biomimetic grafts that c...
Grafting of elastomeric biomaterial scaffolds may offer a radical strategy for the prevention of hea...
Heart tissue engineering is critical in the treatment of myocardial infarction, which may benefit ...
Tissue engineering approaches are currently being investigated for the restoration of myocardial fun...
The heart does not regenerate new functional tissue when myocardium dies following coronary artery o...
AbstractOne of the major challenges in the field of biomaterials engineering is the replication of t...
High-purity cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSCs) are prom...
Heart failure is one of the most debilitating diseases today, and is responsible for one third of al...
Cardiovascular disease is the leading cause of death worldwide. Due to the extremely low natural reg...
Human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) are widely suggested as a suit...
There is currently an overwhelming need for functional replacement of diseased or damaged cardiac ti...
Dilated cardiomyopathy is a major cause of progressive heart failure. Utilization of stem cell thera...